MetabolismSelective Glucocorticoid Receptor Modulation Prevents and Reverses Nonalcoholic Fatty Liver Disease in Male MiceKoorneef et al. • 2018 Endocrinology. 2018, 159(12):3925–3936 30321321 December 3, 2019 https://corcept.com/wp-content/uploads/COR-logo.svg 0 0 imc@healthandcommerce.com https://corcept.com/wp-content/uploads/COR-logo.svg imc@healthandcommerce.com2019-12-03 00:00:002019-12-03 00:00:00Selective Glucocorticoid Receptor Modulation Prevents and Reverses Nonalcoholic Fatty Liver Disease in Male Mice
